A new mode of RAF autoregulation: a further complication in the inhibitor paradox
- PMID: 23680140
- DOI: 10.1016/j.ccr.2013.04.021
A new mode of RAF autoregulation: a further complication in the inhibitor paradox
Abstract
ERK pathway activation in cells expressing wild-type BRAF is a well-reported, clinically-relevant adverse effect of the otherwise impressive response of BRAF(V600E)-mutated melanomas to RAF inhibitors. In this issue of Cancer Cell, Holderfield and colleagues show that RAF autoinhibition underpins this paradox, further complicating therapeutic strategies centered around RAF.
Copyright © 2013 Elsevier Inc. All rights reserved.
Comment on
-
RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation.Cancer Cell. 2013 May 13;23(5):594-602. doi: 10.1016/j.ccr.2013.03.033. Cancer Cell. 2013. PMID: 23680146
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous